Source: BUSINESS WIRE

Press Release: AtheroMed : Research and Markets: MedIntelliBase Lower Limb Critical Limb Ischemia Therapeutics MarketTracksTM ("CLI-LL MarketTracks")

DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/865vlf/medintellibase) has announced the addition of the "MedIntelliBase® Lower Limb Critical Limb Ischemia Therapeutics MarketTracksTM ("CLI-LL MarketTracks")" subscription to their offering. Medical industry executives who rely on timely business intelligence now have two smarter alternatives - MedIntelliBase Alerts and MedIntelliBase MarketTracks services. Both cloud and mobile, fully searchable service

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
25-100
Michael T. MacKinnon's photo - President & CEO of AtheroMed

President & CEO

Michael T. MacKinnon

CEO Approval Rating

70/100

Read more